Status:
UNKNOWN
A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors
Lead Sponsor:
Affiliated Hospital of North Sichuan Medical College
Conditions:
Neutropenia
Eligibility:
All Genders
18+ years
Brief Summary
Prospective, multicenter, non-interventional registration studies were used in this project . Eight hundreds patients with solid tumors who met the inclusion criteria in six hospitals in Sichuan Provi...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old;
- Diagnosed as a malignant solid tumor by histology and cytology, requiring chemotherapy patients;
- The first use of PEG-rhG-CSF during the chemotherapy cycle (not limited to the first chemotherapy cycle, can be any chemotherapy cycle of the patient);
- Subjects volunteered to participate in this clinical trial and signed informed consent.
Exclusion
- PEG-rhG-CSF was used in the current chemotherapy cycle;
- Have received hematopoietic stem cell transplantation or bone marrow transplantation;
- Other drug clinical trials are currently underway.
Key Trial Info
Start Date :
July 6 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 6 2019
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03798665
Start Date
July 6 2018
End Date
July 6 2019
Last Update
January 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Affiliated Hospital of North Sichuan Medical College
Nanchong, Sichuan, China